SCHEMBL11073103

SCHEMBL11073103

COC(=O)c1cc(-c2ccc(Cl)cc2)nn1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
TACR2 P21452 1/20 0.53
TACR1 P25103 1/20 0.53
TACR3 P29371 1/20 0.53
CYP2C19 P33261 1/20 0.53
MAPT P10636 6/20 0.52
RAB9A P51151 3/20 0.52
NPC1 O15118 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
POLB P06746 2/20 0.49
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2730507 0.85 PHGDH (0.58) CYP1A2CYP2D6CYP2C9CYP2C19MAPT
SCHEMBL10957361 0.85 CA12 (0.47) CYP1A2CYP3A4CYP2D6CYP2C9TACR2
SCHEMBL30722849 0.85 HDAC3 (0.56) MAPTRAB9ANPC1SMN1; SMN2CA12
SCHEMBL4298598 0.85 PHGDH (0.59) CA12CA1CA2CA9PHGDH
SCHEMBL5022767 0.85 TSHR (0.58) CYP1A2CYP3A4CYP2D6CYP2C9TACR2
SCHEMBL10960418 0.85 CA12 (0.47) CYP1A2CYP3A4CYP2D6CYP2C9TACR2
SCHEMBL30722873 0.84 CA12 (0.48) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL28014535 0.83 MAPT (0.52) CYP1A2CYP3A4CYP2D6CYP2C9TACR2
SCHEMBL2565586 0.83 MAPT (0.56) CYP1A2CYP3A4CYP2D6CYP2C9TACR2
SCHEMBL3103714 0.82 MAPT (0.51) CYP1A2CYP3A4CYP2D6CYP2C9TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0112623-A2 3-Aryl-5-pyrazole-carboxylic-acid derivatives, their preparation and pharmaceutical compositions ELI LILLY AND COMPANY (US) 1984-07-04 EP disclosed